The Food and Drug Administration is scrambling to bring back hundreds of critical workers laid off en masse by DOGE.

The reversal is the latest example of President Donald Trump and billionaire Elon Musk's chaotic approach to cost-cutting, which has resulted in several agencies firing, and then scrambling to rehire, employees responsible for nuclear weapons, national parks and other government services.

The Trump administration is reinstating some employees in the Food and Drug Administration's medical devices division after dozens were laid off as part of a government-wide cost-cutting initiative led by billionaire Elon Musk and his Department of Government Efficiency,

Twelve deaths have been reported as part of an outbreak of Listeria monocytogenes infections linked to frozen supplemental shakes, the US Food and Drug Administration said Monday. At least 38 people in 21 states had been infected,

The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention said on Monday the agencies were investigating a multi-state outbreak of listeria infections linked to frozen supplemental shakes manufactured by Prairie Farms Dairy Inc.

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug

Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s weight loss drugs without a fight. | Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s weight loss drugs without a fight.

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief medical officer, bringing back an industry veteran to lead its regulatory and drug safety operations.

Pfizer Inc. appointed the Food and Drug Administration’s former top drug reviewer to serve as its chief medical officer.

Pfizer (NYSE:PFE) has tapped Patrizia Cavazzoni, the former head of drug regulation at the FDA, as its new chief medical officer. Cavazzoni was most recently director of the Center for Drug Evaluation and Research (CDER) at the U.